Biomedical Research · 2015 · 48 citations · 11 references
Life SciencesCell BiologyOrthopaedic SurgeryRegenerative MedicineStem Cell BiologyTissue EngineeringCartilage BiologyCartilage RegenerationCartilage Tissue EngineeringEmbryonic Stem CellsStem Cell TumorigenicityTissue Engineering With Stem CellsChondrogenic DifferentiationHuman Embryonic Stem CellsHyaline Cartilage FormationHyaline Cartilage RegenerationImmature TeratomaInduced Pluripotent Stem CellsMature TeratomaStem Cell-based Cartilage Regeneration
Induced pluripotent stem cells (iPSCs) are a promising cell source for cartilage regenerative medicine. Meanwhile, the risk of tumorigenesis should be considered in the clinical application of human iPSCs (hiPSCs). Here, we report in vitro chondrogenic differentiation of hiPSCs and maturation of the differentiated hiPSCs through transplantation into mouse knee joints. Three hiPSC clones showed efficient chondrogenic differentiation using an established protocol for human embryonic stem cells. The differentiated hiPSCs formed hyaline cartilage tissues at 8 weeks after transplantation into the articular cartilage of NOD/SCID mouse knee joints. Although tumors were not observed during the 8 weeks after transplantation, an immature teratoma had developed in one mouse at 16 weeks. In conclusion, hiPSCs are a potent cell source for regeneration of hyaline articular cartilage. However, the risk of tumorigenesis should be managed for clinical application in the future.
11
Directed differentiation of human embryonic stem cells toward chondrocytes
Rachel A. Oldershaw, M. Baxter, Emma T. Lowe et al. · Nature Biotechnology · 2010 · 307 citations
Generation of Scaffoldless Hyaline Cartilaginous Tissue from Human iPSCs
Akihiro Yamashita, Miho Morioka, Yasuhito Yahara et al. · Stem Cell Reports · 2015 · 281 citations · Full text